Daniel Tillett

Daniel Tillett

Chief Executive Officer at RACURA ONCOLOGY LTD

Net worth: 38 M $ as of 30/05/2026

Health Technology
Technology Services
Consumer Services

Profile

Dr. Daniel Tillett is a Chief Executive Officer, MD & Director at Racura Oncology Ltd. He is on the Board of Directors at Entropy Neurodynamics Ltd. and Racura Oncology Ltd. Dr. Tillett was previously employed as a Non-Executive Director by Simble Solutions Ltd., an Executive Director & Chief Scientific Officer by Race Oncology Ltd., and a Chief Executive Officer by Nucleics Ltd. He received his undergraduate degree from School of Biotechnology & Biomolecular Sciences and a doctorate degree from School of Biotechnology & Biomolecular Sciences.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/05/2026 20,269,351 ( 10.64% ) 38 M $ 30/05/2026

Daniel Tillett active positions

CompaniesPositionStart
RACURA ONCOLOGY LTD Chief Executive Officer 21/11/2023

Former positions of Daniel Tillett

CompaniesPositionEnd
SIMBLE SOLUTIONS LIMITED Director/Board Member 02/07/2023
RACURA ONCOLOGY LTD Chief Tech/Sci/R&D Officer 22/03/2023
Nucleics Ltd.
Chief Executive Officer -
See the detail of Daniel Tillett's experience

Training of Daniel Tillett

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

11

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Health Technology

Technology Services

Consumer Services

Nucleics Ltd.

  1. Stock Market
  2. Insiders
  3. Daniel Tillett
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!